T1D, football coach
The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System is the first and only CGM
system approved by the FDA to let you make treatment decisions without pricking your finger,* based
on its readings. The Dexcom G5 Mobile continuously measures your glucose every 5 minutes,
and sends data to a receiver or smart system.** You can share this data with up to 5 followers,***
and set high and low glucose alerts. And knowing more can help you lower A1C levels.†
Know more. Prick less.™
*Fingersticks required for calibration, or if symptoms or expectations
do not match readings, or when taking medications containing acetaminophen.
**For a list of compatible devices, visit www.dexcom.com/compatibility ***Separate Follow app required †JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359( 14):1464-1476.
BRIEF SAFE T Y S TATEMEN T The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System (“G5”) is a glucose monitoring system indicated for the management of diabetes in persons age 2 years and older. The
G5 is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The G5 also aids in the detection of episodes of hyperglycemia and hypoglycemia. The G5 is intended for single patient use
and requires a prescription. CON TRAINDICATIONS Do not rely on the G5 CGM data if you have recently taken acetaminophen. Remove the G5 (sensor, transmitter, and receiver) before Magnetic Resonance Imaging
(MRI), Computed Tomography (C T) scan, or high-frequency electrical heat (diathermy) treatment. The G5 is MR Unsafe. Do not bring any portion of the G5 into the MRI environment. WARNING CGM-based diabetes
treatment decisions are only approved with the G5, not previous generations of Dexcom CGM systems. Calibrate at least once every 12 hours using a fingerstick. If your G5 does not display a sensor glucose reading and
an arrow, or if you are getting inaccurate or inconsistent readings, take a fingerstick. If your glucose readings and alerts do not match your symptoms or expectations, take a fingerstick to confirm. Failure to do so may
lead to hyperglycemia or hypoglycemia. The G5 is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to
remove it. Seek professional medical help if you have infection or inflammation on or near the sensor insertion point. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites
other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). To “share” data, you need an internet connection and a separate compatible smart device running the Dexcom Follow
App. Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information. Internet connectivity required to access Dexcom Follow.
© 2017 Dexcom Inc. All rights reserved. This product is covered by U. S. patent. LBL014743 Rev001
9 hours of team spirit. 1 away game.